Hemant Surgical Industries Ltd
Incorporated in 1989, Hemant Surgical Industries Ltd is in the business of Medical Equipment & Supplies[1]
- Market Cap ₹ 264 Cr.
- Current Price ₹ 253
- High / Low ₹ 253 / 88.2
- Stock P/E 32.5
- Book Value ₹ 60.3
- Dividend Yield 0.00 %
- ROCE 16.4 %
- ROE 13.8 %
- Face Value ₹ 10.0
Pros
- Company has delivered good profit growth of 74.7% CAGR over last 5 years
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Earnings include an other income of Rs.5.11 Cr.
- Working capital days have increased from 42.1 days to 60.9 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Half Yearly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| 51 | 56 | 56 | 60 | 101 | 109 | 106 | 107 | |
| 48 | 53 | 53 | 57 | 95 | 98 | 95 | 97 | |
| Operating Profit | 2 | 3 | 3 | 3 | 6 | 11 | 10 | 9 |
| OPM % | 5% | 5% | 5% | 5% | 6% | 10% | 10% | 9% |
| 0 | 0 | 0 | 1 | 2 | 2 | 4 | 5 | |
| Interest | 1 | 1 | 2 | 2 | 2 | 2 | 1 | 2 |
| Depreciation | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 1 | 1 | 1 | 1 | 6 | 10 | 13 | 11 |
| Tax % | 10% | 8% | 41% | 9% | 25% | 24% | 23% | 23% |
| 1 | 1 | 0 | 1 | 5 | 8 | 10 | 8 | |
| EPS in Rs | 50.76 | 61.02 | 27.00 | 73.43 | 248.92 | 9.95 | 9.39 | 7.79 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 14% |
| 3 Years: | 2% |
| TTM: | 1% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 75% |
| 3 Years: | 21% |
| TTM: | -17% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 49% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 23% |
| 3 Years: | 22% |
| Last Year: | 14% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 2 | 2 | 2 | 2 | 2 | 8 | 10 | 10 |
| Reserves | 5 | 6 | 5 | 8 | 11 | 16 | 44 | 53 |
| 9 | 11 | 14 | 14 | 10 | 7 | 7 | 31 | |
| 12 | 14 | 23 | 15 | 32 | 34 | 35 | 54 | |
| Total Liabilities | 28 | 33 | 44 | 40 | 54 | 65 | 97 | 148 |
| 7 | 8 | 10 | 11 | 12 | 13 | 18 | 40 | |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12 |
| Investments | 0 | 0 | 1 | 0 | 1 | 0 | 5 | 1 |
| 21 | 25 | 33 | 29 | 42 | 51 | 74 | 94 | |
| Total Assets | 28 | 33 | 44 | 40 | 54 | 65 | 97 | 148 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| 0 | 0 | 2 | -4 | 12 | 6 | -8 | 9 | |
| 0 | 0 | -2 | -2 | -0 | -3 | -9 | -30 | |
| 0 | 0 | 2 | 5 | -8 | -1 | 21 | 18 | |
| Net Cash Flow | 0 | 0 | 2 | -2 | 4 | 3 | 5 | -4 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 35 | 36 | 35 | 26 | 56 | 58 | 75 | 70 |
| Inventory Days | 64 | 73 | 125 | 113 | 57 | 67 | 99 | 205 |
| Days Payable | 102 | 97 | 143 | 89 | 92 | 110 | 116 | 188 |
| Cash Conversion Cycle | -3 | 12 | 17 | 51 | 21 | 15 | 58 | 87 |
| Working Capital Days | 12 | 23 | -28 | 41 | -19 | 2 | 63 | 61 |
| ROCE % | 15% | 12% | 14% | 32% | 45% | 30% | 16% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
11 Aug - Newspaper Add with respect to dispatch the Notice of the Extra-Ordinary General Meeting to be held on Saturday, August 30, 2025
-
Dispatch Of Letter To Shareholders Whose E-Mail Addresses Are Not Registered With Company/Registrar & Transfer Agent/Depository Participants
8 Aug - Dispatch of letter to shareholders without email for EGM notice access on August 30, 2025.
-
Notice Of An Extra-Ordinary General Meeting Of The Company
8 Aug - EGM to approve Rs.16 Cr authorized capital, issue 21L warrants and 26L shares at Rs.197 each.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
7 Aug - Newspaper Add of intimation to hold a Extra Ordinary General Meeting
-
Board Meeting Outcome for Held On Wednesday, August 06, 2025
6 Aug - Approved Rs. 92.59 Cr preferential equity and warrant issue; EGM on Aug 30 for approval.
Business Overview:[1][2]
HSIL is ISO 9001:2015, ISO 13485:2016 certified and CDSCO compliant company which deals in importing, manufacturing, and marketing medical disposable, surgical equipments and pharmaceutical products including
a) Supply of dialysis equipment, renal care, oxygen concentrators, air mattresses, ultrasound machines and digital thermometers, etc.
b) Design and manufacture of a range of nebulisers, which are
marketed under the company’s AERO brand
c) HSIL also refurbishes second-hand dialysis machines, manufactures
and supplies related accessories, dialysers and haemodialysis solutions